US Patent 7816377 Tubulysin analogues

Patent 7816377 was granted and assigned to R&D-Biopharmaceuticals GmbH on October, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

‌

R&D-Biopharmaceuticals GmbH

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

78163770

Patent Inventor Names

Katrin Illgen0

Bernd Henkel0

Sukumar Sakamuri0

Sanjay Menon0

Alexander Dömling0

Barbara Beck0

Date of Patent

October 19, 2010

Patent Application Number

105207930

Date Filed

July 9, 2003

Patent Primary Examiner

‌

Celia Chang

Patent abstract

The invention relates to tubulysin derivatives of general formula (II), said derivatives having a cytostatic effect.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7816377 Tubulysin analogues

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API